Genetic Neurodegenerative Diseases

Genetic neurodegenerative diseases arise when inherited mutations—often expansions of short DNA repeat sequences—drive the progressive breakdown of specific neuronal populations. In conditions like Huntington's disease and the spinocerebellar ataxias, a mutant protein bearing an abnormally long polyglutamine tract misfolds, recruits other proteins into toxic aggregates, and disrupts mitochondrial function and gene expression in ways that cells cannot fully correct; in a related set of disorders like myotonic dystrophy, it is the mutant RNA itself, rather than its protein product, that sequesters essential cellular machinery and triggers degeneration. Researchers are working to understand why neurons in particular circuits succumb while others survive, and how molecular chaperones—proteins that normally assist in folding and clearing aberrant proteins—become overwhelmed or subverted in disease. A central open question is whether therapeutic strategies that reduce aggregate burden, restore mitochondrial health, or correct dysregulated gene expression can intervene late enough in life to slow or halt neuronal loss once symptoms have already begun.

Works

86,756

Total citations

1,711,882

Keywords

Huntington's DiseaseProtein AggregationPolyglutamineMitochondrial DysfunctionRNA-Mediated DisordersAtaxia